Clinical trials recruiting for Prostate Carcinoma
35
Recruiting trials
23
US states with sites
5
Countries
20%
Accept healthy volunteers
Phase breakdown
Drugs and treatments being studied
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| California | 14 |
| Florida | 4 |
| Minnesota | 4 |
| Oregon | 4 |
| Michigan | 3 |
| Massachusetts | 2 |
| Texas | 2 |
| Washington | 2 |
| Arizona | 1 |
| Colorado | 1 |
| Georgia | 1 |
| Hawaii | 1 |
Top cities
Los Angeles, California 7Duarte, California 4Portland, Oregon 4Jacksonville, Florida 3Rochester, Minnesota 3San Francisco, California 3Ann Arbor, Michigan 2Boston, Massachusetts 2Atlanta, Georgia 1Bethesda, Maryland 1
Self-screener
Recruiting trials
- 99mTc-PSMA-I&S Biodistribution in Patients With Prostate Cancer
- A Self-Monitoring Platform for Tracking Medication Safety and Concerns in Cancer Patients
- An Investigational Scan (18F-rhPSMA-7.3 PET-mpMRI) for Targeted Prostate Biopsy Using TRUS-MR Fusion Technique
- An Investigational Scan (Flotufolastat F 18 PET/CT) for Detecting Residual or Recurrent Disease in Patients Who Completed Focal Therapy for Prostate Cancer.
- Androgen Ablation Therapy With or Without Niraparib After Radiation Therapy for the Treatment of High-Risk Localized or Locally Advanced Prostate Cancer
- Breathing Practice for Brain and Mental Health in Cancer and Neurodegenerative Diseases
- Bright White Light Therapy in Reducing Cancer-Related Fatigue and Depression in Advanced Prostate Cancer Patients Undergoing Treatment With ADT Combination Therapy
- Building Community Living Labs in Black Communities to Advance Prostate Health Equity and Reduce Prostate Cancer Disparities in Black Men
- Community-Based Health Coach for Access to Germline Genetic Testing Among African American Men With Prostate Cancer
- Comparing a New PSMA Imaging Agent to MRI for Detecting Prostate Cancer, BEACON Trial
- EMBRACE: Exercising Together
- Exploring the Correlation Between MRI Image Characteristics and Diagnosis, Pathology and Prognosis in Patients With Prostate Lesions
- Exploring the Potential of Robotic Telesurgery in Remote Settings
- GET FIT Together: Testing a Socially Enhanced Exercise Program in Older Men With Prostate Cancer
- Impact of Using the Airseal System With Ultra-low Pneumoperitoneum in Patients Undergoing Robot-assisted Radical Prostatectomy: A Prospective, Comparative, Randomized Clinical Study.
- Integrating Quantitative MRI and Artificial Intelligence to Improve Prostate Cancer Classification
- Internet-Based Lifestyle Intervention to Eradicate Obese Frailty in Prostate Cancer Survivors, iLIVE
- Light Therapy and Occupational Therapy Fatigue Management-Based Intervention for Patients With Genitourinary Cancers
- Longitudinal Advanced Prostate Cancer Cohort (LAPCC)
- Low-Intensity Extracorporeal Shockwave Therapy on Penile Rehabilitation After Robot-assisted Surgical Treatment of Genitourinary Cancers
- MRI-Based Machine Learning Approach Versus Radiologist MRI Reading for the Detection of Prostate Cancer, The PRIMER Trial
- MRI-guided Transurethral Urethral Ultrasound Ablation for the Treatment of Low to Intermediate Grade Prostate Cancer
- Metabolic Interventions (Time-Restricted Eating, GLP1 Receptor Agonist, and Heart Healthy Diet) to Improve Cardiometabolic Health in Prostate Cancer Patients During Androgen Deprivation Therapy, IMPACT-ADT Trial
- Pembrolizumab Plus 177Lu-PSMA-617 in Patients With Castration Resistant Prostate Cancer
- Phase 2 Randomized Trial of Flexible Dosing Schedule of 177Lu-PSMA-617 for the Treatment of Metastatic Castration-Resistant Prostate Cancer (FLEX-MRT)
- Proof-of-Concept Trial to Assess the Efficacy and Safety of Fezolinetant in Improving Vasomotor Symptoms in Men With Prostate Cancer Undergoing Androgen Deprivation Therapy
- Prostate Cancer Screening for People at Genetic Risk for Aggressive Disease, PATROL Study
- Radiation Therapy With RapidPlan Knowledge-based Planning vs Human-Driven Planning for Treatment of Prostate Cancer
- Reduced Length of ADT and ARTA With XRT in High-Risk Prostate Cancer (RELAX): A Randomised Trial
- Reduction of Gastrointestinal Toxicity in Prostate Cancer by Proton Spot Placement
- Screening and Staging of Benign vs Malignant Pelvic Abnormalities
- Targeted Early Detection Program in Men at High Genetic Risk for Prostate Cancer
- The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas
- The Vanguard Study: Testing a New Way to Screen for Cancer
- Transperineal Micro-ultrasound for the Detection of Prostate Cancer During Biopsy
Related conditions
Trials recruiting for Prostate Carcinoma often also study these conditions. Each links to its own recruiting-trial list.
Prostate cancer 1234Malignant Solid Neoplasm 30Breast Carcinoma 74Lung Carcinoma 30Lung cancer 2180Colorectal Carcinoma 42Breast cancer 2239Bladder Carcinoma 6Stage III Prostate Cancer AJCC v8 19Recurrent Prostate Carcinoma 4
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Prostate Carcinoma trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.